وثيقة

Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery.

المعرف
DOI 10.5001/omj.2014.76
مؤلف
المساهمون
الناشر
Oman Medical Specialty Board.
ميلادي
2014-07
اللغة
الأنجليزية
الملخص الإنجليزي
The risk of thrombosis is high in patients with essential thrombocythemia. Special precaution needed for those patients who will undergo Coronary artery bypass grafting. We are reporting a 62 years old patient with ischemic heart disease who was found to have essential thrombocythemia. This report explains the preoperative management and the postoperative risks anticipated due to the treatment.
zcustom_txt_2
Ziadinov, Edem, Al-Sabti, Hilal, Al-Toubi, Malik, & Siddiqi, Mohammad Salman (2014). Pretreatment with hydroxyurea of the patient with essential thrombocythemia followed by coronary artery bypass surgery. Oman Medical Journal, 29 (4), 294-295.
قالب العنصر
مقالات الدوريات

مواد أخرى لنفس الموضوع

مقالات الدوريات
0
0
Aladily, Tariq.
Oman Medical Specialty Board.
2017-05
مقالات الدوريات
0
0
Jose, Jimmy.
Oman Medical Specialty Board.
2019-07